Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Rectal Neoplasms × envafolimab × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2 Biliary Tract Neoplasms 2 Rectal Neoplasms 1 Rare Tumour 1 Osteosarcoma 1 Locally Advanced Rectal Carcinoma 1 Gastrointestinal Stromal Tumors 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Renal Cell Carcinoma (aRCC) 1 Advanced Refractory Solid Tumors 1

Interventions

Oxaliplatin 14 Capecitabine 11 Fluorouracil 6 Surgical Procedures, Operative 5 Radiotherapy 5 Drug Therapy 5 Irinotecan 4 tislelizumab 3 Neoadjuvant Therapy 3 Immunotherapy 3 Endoscopic Mucosal Resection 3 Bevacizumab 3 sintilimab 2 raltitrexed 2 XELOX 2 Leucovorin 2 FOLFOXIRI protocol 2 zanidatamab 1 trifluridine tipiracil drug combination 1 toripalimab 1 sperm releasing substance 1 spartalizumab 1 saxagliptin 1 envafolimab 1 cemiplimab 1 camrelizumab 1 X-Rays 1 Water 1 Watchful Waiting 1 Trinitrotoluene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05969847 2023-08-01

TRACE-LE

Fujian Medical University Union Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡